Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kublin, James"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-8 z 8
    Tytuł:
    PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
    Autorzy:
    Murphy SC; Seattle Malaria Clinical Trials Center, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.; Center for Emerging and Re-emerging Infectious Diseases, Seattle, Washington, United States of America.
    Deye GA; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
    Sim BKL; Sanaria Inc., Rockville, Maryland, United States of America.
    Galbiati S; The Emmes Company, Rockville, Maryland, United States of America.
    Kennedy JK; The Emmes Company, Rockville, Maryland, United States of America.
    Cohen KW; Seattle Malaria Clinical Trials Center, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Chakravarty S; Sanaria Inc., Rockville, Maryland, United States of America.
    Kc N; Sanaria Inc., Rockville, Maryland, United States of America.
    Abebe Y; Sanaria Inc., Rockville, Maryland, United States of America.
    James ER; Sanaria Inc., Rockville, Maryland, United States of America.
    Kublin JG; Seattle Malaria Clinical Trials Center, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
    Hoffman SL; Sanaria Inc., Rockville, Maryland, United States of America.
    Richie TL; Sanaria Inc., Rockville, Maryland, United States of America.
    Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2021 May 28; Vol. 17 (5), pp. e1009594. Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
    Typ publikacji:
    Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
    MeSH Terms:
    Vaccination*
    Antimalarials/*administration & dosage
    Malaria Vaccines/*immunology
    Malaria, Falciparum/*prevention & control
    Plasmodium falciparum/*immunology
    Adult ; Erythrocytes/immunology ; Female ; Humans ; Immunogenicity, Vaccine ; Malaria Vaccines/administration & dosage ; Malaria, Falciparum/parasitology ; Middle Aged ; Parasitemia ; Sporozoites ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs.
    Autorzy:
    Hanron AE; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA.
    Billman ZP; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA.; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, 750 Republican St., Seattle, WA, 98109, USA.
    Seilie AM; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA.
    Olsen TM; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA.
    Fishbaugher M; Center for Infectious Disease Research, 307 Westlake Ave. N, #500, Seattle, WA, 98109, USA.
    Chang M; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA.
    Rueckle T; Medicines for Malaria Venture, PO Box 1826, 20, Route de Pré-Bois, 1215, Geneva, Switzerland.
    Andenmatten N; Medicines for Malaria Venture, PO Box 1826, 20, Route de Pré-Bois, 1215, Geneva, Switzerland.
    Greenhouse B; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, USA.
    Arinaitwe E; Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.; London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
    Rek J; Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
    Das S; PATH, 2201 Westlake Ave #200, Seattle, WA, 98121, USA.
    Domingo GJ; PATH, 2201 Westlake Ave #200, Seattle, WA, 98121, USA.
    Shipman K; Seattle Malaria Clinical Trials Center, Fred Hutch Cancer Research Center, 1100 Fairview Ave. N., #E3-300, Seattle, WA, 98109, USA.
    Kappe SH; Center for Infectious Disease Research, 307 Westlake Ave. N, #500, Seattle, WA, 98109, USA.
    Kublin JG; Seattle Malaria Clinical Trials Center, Fred Hutch Cancer Research Center, 1100 Fairview Ave. N., #E3-300, Seattle, WA, 98109, USA.
    Murphy SC; Department of Laboratory Medicine, University of Washington, 750 Republican St., E630, Seattle, WA, 98109, USA. .; Department of Microbiology, University of Washington, 1959 NE Pacific St., Seattle, WA, 98195, USA. .; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, 750 Republican St., Seattle, WA, 98109, USA. .; Center for Infectious Disease Research, 307 Westlake Ave. N, #500, Seattle, WA, 98109, USA. .
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2017 May 19; Vol. 16 (1), pp. 208. Date of Electronic Publication: 2017 May 19.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Multiplex Polymerase Chain Reaction/*methods
    Plasmodium falciparum/*genetics
    RNA, Messenger/*genetics
    RNA, Protozoan/*genetics
    RNA, Ribosomal, 18S/*genetics
    Reverse Transcriptase Polymerase Chain Reaction/*methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.
    Autorzy:
    Talley AK; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Healy SA; Laboratory for Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
    Finney OC; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Murphy SC; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, United States of America.
    Kublin J; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Salas CJ; United States Naval Medical Research Unit Number 6, Lima, Peru.
    Lundebjerg S; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Gilbert P; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Van Voorhis WC; Department of Medicine, University of Washington Medical Center, Seattle, Washington, United States of America.
    Whisler J; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Wang R; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Ockenhouse CF; United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
    Heppner DG; United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
    Kappe SH; Malaria Clinical Trials Center, Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
    Duffy PE; Laboratory for Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Nov 18; Vol. 9 (11), pp. e109654. Date of Electronic Publication: 2014 Nov 18 (Print Publication: 2014).
    Typ publikacji:
    Clinical Trial; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Human Experimentation*
    Sporozoites*
    Malaria, Falciparum/*diagnosis
    Plasmodium falciparum/*pathogenicity
    Adult ; Animals ; Anopheles/parasitology ; Anopheles/physiology ; Bites and Stings/parasitology ; Female ; Humans ; Malaria, Falciparum/complications ; Malaria, Falciparum/etiology ; Malaria, Falciparum/immunology ; Male ; Plasmodium falciparum/physiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.
    Autorzy:
    Kublin, James G.
    Patnaik, Padmaja
    Jere, Charles S.
    Miller, William C.
    Hoffman, Irving F.
    Chimbiya, Nelson
    Pendame, Richard
    Taylor, Terrie E.
    Molyneux, Malcolm E.
    Pokaż więcej
    Źródło:
    Lancet. 1/15/2005, Vol. 365 Issue 9455, p233-240. 8p. 1 Diagram, 2 Charts, 2 Graphs.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites
    Autorzy:
    Edelman, Robert
    Wasserman, Steven S.
    Kublin, James G.
    Bodison, Sacared A.
    Nardin, Elizabeth H.
    Oliveira, Giane A.
    Ansari, Sobia
    Diggs, Carter L.
    Kashala, Oscar L.
    Schmeckpeper, Barbara J.
    Hamilton, Robert G.
    Pokaż więcej
    Źródło:
    Vaccine. Dec2002, Vol. 21 Issue 3/4, p269. 12p.
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-8 z 8

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies